News
/
Prabjot Hunjan joins Arriello
as Director of Global Drug Safety.
Arriello welcomes another senior pharmacovigilance leader to our growing team of PV experts.
Prabjot joins Arriello’s Pharmacovigilance team with over 16 years of experience across both clinical trials and post-marketing within European and Global PV operations, both in CROs and pharma, and with six years in management.
His CRO & pharma experience includes director-level management, leading and developing the Pharmacovigilance function whilst delivering Pharmacovigilance Quality and Process Improvements.
Prabjot has also acted as EU QPPV and Deputy on behalf of Marketing Authorization Holders in the EU and has worked within a large team as a program and product lead on a well-established MS product.
Prabjot is also a trained auditor and experienced in EU GDPR as a Data Protection Officer.
He will report to Arriello’s VP of Global Dug Safety @kieranodonnell
Latest news.
View allIndustrial microbiology and quality risk management specialist Kate Coleman will join Arriello in September as VP of Quality & Compliance.
We are pleased to announce we will be in Amsterdam, The Netherlands, for the RAPS Euro Convergence 2023 from 10 to 12 May.
Sonia has 20 years of experience in global and local pharmacovigilance in both large pharma and service provider organizations.
